Back to the main directory
SurveyAnalysisAndResults / Equity
- VGP NV : VGP Park Nijmegen visit provides key insights on Dutch and European logistics real estate market; we raise TP to € 125 by Oddo BHF
- ODDO : Monday Luxury Review by Oddo BHF
- STMicroelectronics N.V. : La publication et la guidance devraient être comme attendu, ce qui serait positif après la déception du T2 by Oddo BHF
- AstraZeneca : Un rôle élargi pour Enhertu dans le HER2+ ; une avancée majeure pour Datroway by Oddo BHF
- Autoliv : Un T3 2025 solide et toujours des leviers d’amélioration by Oddo BHF
- Forvia : Q3 2025 sales in line, FY outlook confirmed by Oddo BHF
- Accor : What to expect from the Q3 2026 results (on 23 October) by Oddo BHF
- Aixtron SE : Preliminary Q3 2025 results and cut to 2025 guidance point to persistently weak demand, but our view of an inflexion point around H1 2026 maintained by Oddo BHF
- Volvo AB : A cautious first look at 2026 by Oddo BHF
- Aixtron SE : Preliminary Q3 2025 results and cut to 2025 guidance point to persistently weak demand, but our view of an inflexion point around H1 2026 maintained by Oddo BHF
- SLB : North American business acting as a drag, but shareholder returns remain solid by Oddo BHF
- Rio Tinto Plc : Attentes 2025 relevées grâce aux cours des métaux, Simandou on track by Oddo BHF
- STMicroelectronics N.V. : The publication and the guidance should be as expected, which would be positive after the disappointment in Q2 by Oddo BHF
- ODDO : Obstacles and solutions to a transaction by Oddo BHF
- Capgemini : Further modest recovery expected in Q3 and Q4. We factor in the integration of WNS Holdings by Oddo BHF
- Atos : CA au T3 inférieur aux attentes, menant à une révision à la baisse de la guidance de CA FY 2025 mais guidance de ROA réitérée by Oddo BHF
- Neinor Homes SA : Neinor receives shareholder approval to proceed with voluntary tender offer over AEDAS as it reiterates FY 2025 targets by Oddo BHF
- L'Oréal : Pourquoi le T3 pourrait être une bonne surprise ? Et pourquoi elle pourrait être bien accueillie ? by Oddo BHF
- AALBERTS : Updated estimates and TP, Outperform reiterated by Oddo BHF
- Planisware : T3 2025 légèrement supérieur aux attentes et guidances FY réitérées by Oddo BHF
- BNP Paribas : Hausse attendue du RN de 8% au T3 by Oddo BHF
- KBC : Good NII & non-life in 3Q25, rise of commission income, best solvency by Oddo BHF
- TeamViewer SE : Q3 preview: FX headwinds likely to put pressure on the top line; margins remain strong by Oddo BHF
- Grifols B : Q3 preview: flattish headline EBITDA evolution on FX headwinds by Oddo BHF
- Laboratorios Rovi : Collaboration with Roche to manufacture a new treatment by Oddo BHF